MSB 3.21% $1.13 mesoblast limited

Ann: FDA Grants RMAT Designation for Rexlemestrocel-L in CLBP, page-131

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    @otherperspective, I wouldn’t worry too much about the share price and conspiracy theories over tree shakes etc. we have made new highs, have increasing volume and will hopefully have a higher low. Once the FDA accepts the BLA, I think this will run up to 1.80-$2 easy, I was actually surprised at how much of a run the share price has had over the last few days and wanted to see it settle and consolidate. Moving averages are all crossing over and the chart is looking good, just need to keep the positive news coming. Appreciate your posts!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.